BERKELEY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: QUCY) doing business as Quantum Cyber (the “Company” or “Quantum Cyber”), today announced a strategic update in response to the Trump Administration’s newly released National Cybersecurity Strategy, outlining the Company’s positioning within the rapidly evolving quantum and cyber defense landscape. The Company also disclosed the pre-funding of the second tranche pursuant to a previously announced private placement with lead shareholder David Lazar.
Read more at globenewswire.com